Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5701 to 5715 of 7707 results

  1. The evidence on transvaginal laser therapy for urogenital atrophy does not show any short-term safety concerns. Evidence on long-term safety and efficacy is inadequate in quality and quantity. Therefore, this procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page.

    Recommendation ID IPG697/1 Question The evidence on transvaginal laser therapy for urogenital atrophy does not show any short-term safety

    Research recommendation
    Published
    10 August 2021

  2. Antipyretics: The GDG recommends that studies are conducted in primary care and secondary care to determine whether examination or re-examination after a dose of antipyretic medication is of benefit in differentiating children with serious illness from those with other conditions.

    Recommendation ID NG143/04 Question Antipyretics: The GDG recommends that studies are conducted in primary care and secondary care to determine

    Research recommendation
    Published
    17 December 2021

  3. The experience of consenting for organ donation:- Does a positive experience of approach and process of consent for families increase consent rates?

    Recommendation ID CG135/5 Question The experience of consenting for organ donation:- Does a positive experience of approach and process

    Research recommendation
    Published
    9 June 2015

  4. Symptoms and signs of serious illness: The Guideline Development Group (GDG) recommends a UK-based epidemiological study on the symptoms and signs of serious illness.

    Recommendation ID NG143/01 Question Symptoms and signs of serious illness: The Guideline Development Group (GDG) recommends a UK-based

    Research recommendation
    Published
    17 December 2021

  5. The health-related quality-of-life evidence of patients with perianal fistulas is also lacking, therefore further research is recommended. Any research should measure the effect of treatment using preference-based measures (such as use of the EQ-5D questionnaire).

    Recommendation ID TA556/2 Question The health-related quality-of-life evidence of patients with perianal fistulas is also lacking, therefore

    Research recommendation
    Published
    19 March 2019

  6. The physical health benefits of discontinuing antipsychotic medication:- What are the short- and long-term benefits to physical health of guided medication discontinuation and/or reduction in first episode psychosis and can this be achieved without major risks?

    Recommendation ID CG178/3 Question The physical health benefits of discontinuing antipsychotic medication:- What are the short- and long-term

    Research recommendation
    Published
    9 June 2015

  7. There have been no head-to-head trials of rivaroxaban compared with a low molecular weight heparin for people who have cancer and experience an acute pulmonary embolism or deep vein thrombosis. As in NICE technology appraisal guidance 261 it is recommended that further research should be carried out.

    Recommendation ID TA287/1 Question There have been no head-to-head trials of rivaroxaban compared with a low molecular weight heparin for

    Research recommendation
    Published
    9 June 2015

  8. There is a need for additional research on the management of bleeds that occur while people are receiving apixaban, rivaroxaban or dabigatran etexilate, as there are no antidotes or established treatments to stop active bleeding for these agents.

    Recommendation ID TA275/1 Question There is a need for additional research on the management of bleeds that occur while people are receiving

    Research recommendation
    Published
    9 June 2015

  9. There is a need for further evidence on the long-term outcomes of treatment with eculizumab, and on the effect of treatment in children, adolescents and during pregnancy. The Committee supports enrolment of patients into the aHUS registry and the collection of high-quality information from these registries periodically to inform treatment decisions.

    Recommendation ID HST1/2 Question There is a need for further evidence on the long-term outcomes of treatment with eculizumab, and on the

    Research recommendation
    Published
    9 June 2015

  10. What are the benefits of a primary care-based collaborative care approach to improving the treatment of generalised anxiety disorder (GAD) compared with usual care?

    Recommendation ID CG113/5 Question What are the benefits of a primary care-based collaborative care approach to improving the treatment

    Research recommendation
    Published
    9 June 2015

  11. Clinical features for distinguishing between type 1 diabetes and other types of diabetes: What are the best clinical features or combination of features for distinguishing between type 1 diabetes and other types of diabetes?

    Recommendation ID NG17/01 Question Clinical features for distinguishing between type 1 diabetes and other types of diabetes: What are the

    Research recommendation
    Published
    11 April 2022

  12. Measuring shared decision making: What are the best ways to measure the effectiveness of shared decision making in different contexts (in different settings and involving different people)?

    Recommendation ID NG197/2 Question Measuring shared decision making: What are the best ways to measure the effectiveness of shared decision

    Research recommendation
    Published
    10 August 2021

  13. What are the causative and contributory factors underlying the persistently very low levels of reported patient satisfaction for bladder cancer?

    Recommendation ID NG2/1 Question What are the causative and contributory factors underlying the persistently very low levels of reported

    Research recommendation
    Published
    9 June 2015

  14. Diagnosing COPD: -  What are the characteristics of people diagnosed with COPD as a result of an incidental finding ofemphysema on a CT scan, compared with those diagnosed with symptoms?

    Recommendation ID NG115/6 Question Diagnosing COPD: - What are the characteristics of people diagnosed with COPD as a result of an incidental

    Research recommendation
    Published
    13 February 2019

  15. What are the clinical and cost effectiveness, and the safety, of specific antifungal treatments for treating suspected or confirmed COVID-19-associated pulmonary aspergillosis (CAPA), and the optimal treatment duration? When should treatment be started, stopped or modified?

    Recommendation ID NG191/14 Question What are the clinical and cost effectiveness, and the safety, of specific antifungal treatments for

    Research recommendation
    Published
    9 March 2022